Next generation sequencing in cancer research and clinical application

http://www.biologicalproceduresonline.com/content/15/1/4

Recent NGS-based studies in cancer
Cancer Experiment Design Description ref
Colon cancer 72 WES, 68 RNA-seq, 2 WGS Identify multiple gene fusions such as RSPO2 and RSPO3 from RNA-seq that may function in tumorigenesis [15]
Breast cancer 65 WGS/WES, 80 RNA-seq 36% of the mutations found in the study were expressed. Identify the abundance of clonal frequencies in an epithelial tumor subtype [11]
Hepatocellular carcinoma 1 WGS, 1 WES Identify TSC1 nonsense substitution in subpopulation of tumor cells, intra-tumor heterogeneity, several chromosomal rearrangements, and patterns in somatic substitutions [17]
Breast cancer 510 WES Identify two novel protein-expression-defined subgroups and novel subtype-associated mutations [5]
Colon and rectal cancer 224 WES, 97 WGS 24 genes were found to be significantly mutated in both cancers. Similar patterns in genomic alterations were found in colon and rectum cancers [14]
squamous cell lung cancer 178 WES, 19 WGS, 178 RNA-seq, 158 miRNA-seq Identify significantly altered pathways including NFE2L2 and KEAP1 and potential therapeutic targets [16]
Ovarian carcinoma 316 WES Discover that most high-grade serous ovarian cancer contain TP53 mutations and recurrent somatic mutations in 9 genes [13]
Melanoma 25 WGS Identify a significantly mutated gene, PREX2 and obtain a comprehensive genomic view of melanoma [20]
Acute myeloid leukemia 8 WGS Identify mutations in relapsed genome and compare it to primary tumor. Discover two major clonal evolution patterns [21]
Breast cancer 24 WGS Highlights the diversity of somatic rearrangements and analyzes rearrangement patterns related to DNA maintenance [8]
Breast cancer 31 WES, 46 WGS Identify eighteen significant mutated genes and correlate clinical features of oestrogen-receptor-positive breast cancer with somatic alterations [7]
Breast cancer 103 WES, 17 WGS Identify recurrent mutation in CBFB transcription factor gene and deletion of RUNX1. Also found recurrent MAGI3-AKT3 fusion in triple-negative breast cancer [6]
Breast cancer 100 WES Identify somatic copy number changes and mutations in the coding exons. Found new driver mutations in a few cancer genes [9]
Acute myeloid leukemia 24 WGS Discover that most mutations in AML genomes are caused by random events in hematopoietic stem/progenitor cells and not by an initiating mutation [22]
Breast cancer 21 WGS Depict the life history of breast cancer using algorithms and sequencing technologies to analyze subclonal diversification [12]
Head and neck squamous cell carcinoma 32 WES Identify mutation in NOTCH1 that may function as an oncogene [19]
Renal carcinoma 30 WES Examine intra-tumor heterogeneity reveal branch evolutionary tumor growth

Leave a Comment

Scroll to Top